Skip to main content

Luspatercept-aamt

(lus-PA-ter-cept)

This page contains brief information about luspatercept-aamt and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Reblozyl
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Luspatercept-aamt is approved to treat:

Luspatercept-aamt is also being studied in the treatment of other conditions.

More About Luspatercept-aamt

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Clinical Trials Accepting Patients

Find Clinical Trials for Luspatercept-aamt - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: